- Home
- DKNG vs MRNA Comparison
DKNG vs MRNA Comparison
Compare DKNG & MRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DKNG
- MRNA
- Stock Information
- Founded
- DKNG 2012
- MRNA 2010
- Country
- DKNG United States
- MRNA United States
- Employees
- DKNG N/A
- MRNA N/A
- Industry
- DKNG Services-Misc. Amusement & Recreation
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DKNG Consumer Discretionary
- MRNA Health Care
- Exchange
- DKNG Nasdaq
- MRNA Nasdaq
- Market Cap
- DKNG 19.8B
- MRNA 16.5B
- IPO Year
- DKNG N/A
- MRNA 2018
- Fundamental
- Price
- DKNG $38.75
- MRNA $38.36
- Analyst Decision
- DKNG Strong Buy
- MRNA Hold
- Analyst Count
- DKNG 25
- MRNA 19
- Target Price
- DKNG $50.72
- MRNA $79.50
- AVG Volume (30 Days)
- DKNG 7.4M
- MRNA 7.7M
- Earning Date
- DKNG 02-13-2025
- MRNA 11-07-2024
- Dividend Yield
- DKNG N/A
- MRNA N/A
- EPS Growth
- DKNG N/A
- MRNA N/A
- EPS
- DKNG N/A
- MRNA N/A
- Revenue
- DKNG $4,605,784,000.00
- MRNA $5,081,000,000.00
- Revenue This Year
- DKNG $36.82
- MRNA N/A
- Revenue Next Year
- DKNG $29.89
- MRNA N/A
- P/E Ratio
- DKNG N/A
- MRNA N/A
- Revenue Growth
- DKNG 40.01
- MRNA N/A
- 52 Week Low
- DKNG $28.69
- MRNA $35.80
- 52 Week High
- DKNG $49.57
- MRNA $170.47
- Technical
- Relative Strength Index (RSI)
- DKNG 37.96
- MRNA 35.63
- Support Level
- DKNG $42.39
- MRNA $41.06
- Resistance Level
- DKNG $41.16
- MRNA $44.38
- Average True Range (ATR)
- DKNG 1.62
- MRNA 2.57
- MACD
- DKNG -0.68
- MRNA 0.16
- Stochastic Oscillator
- DKNG 6.50
- MRNA 1.74
About DKNG DraftKings Inc.
DraftKings got its start in 2012 as an innovator in daily fantasy sports. Then, following a Supreme Court ruling in 2018 that allowed states to legalize online sports wagering, the company expanded into online sports and casino gambling, where it generally holds the number two or three revenue share position across states in which it competes. DraftKings is now live with online or retail sports betting in about 30 states and iGaming in seven states, with both products available to around 40% of Canada's population. The company also operates a non-fungible token commissioned-based marketplace and develops and licenses online gaming products.
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.